[1]
“Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial”, Ital J Med, vol. 1, no. 1, pp. 32–36, May 2013, doi: 10.4081/itjm.2007.1.32.